Oral cancer is an aggressive disease with the propensity for local recurrence and distal
metastasis in the head and neck region. Currently, cisplatin-based chemotherapy or …

Objective Oral cancer is the sixteenth most prevalent cancer in the world and the third-most
in India. Despite of several treatment modalities, the cure rate of oral cancer is still low due to …

Oral cancer is a sub-category of head and neck cancers that primarily initiates in the oral
cavity. The primary treatment option for oral cancer remains surgery but it is associated with …

Oral squamous cell carcinoma (OSCC) is a kind of malignant tumors with low survival rate
and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which …

Chemotherapy resistance is a huge barrier for head and neck cancer (HNC) patients and
therefore requires close attention to understand its underlay mechanisms for effective …

Oral squamous cell carcinoma (OSCC), the eighth most prevalent cancer in the world, arises
from the interaction of multiple factors including tobacco, alcohol consumption, and betel …

Oral cancer ranks sixth most prevalent type of cancer worldwide due to its alarming increase
every year. Progression of oral cancer depends on various heterogeneity pathways, but their …

Cisplatin is one of the most widely used anticancer agents for patients with tongue
squamous cell carcinoma (TSCC), but its efficacy is limited by chemoresistance …

Cisplatin is one of the major drugs used in oral cancer treatments, but its usage can be
limited by acquired drug resistance. In this study, we established three cisplatin-resistant …

Although, there is a high rate of good prognosis in early stage head and neck tumors, about
half of these tumors are detected in advanced stages with poor prognosis. A combination of …